Aclaris Therapeutics, Inc. – ‘8-K’ for 5/26/23

On:  Thursday, 6/1/23, at 4:18pm ET   ·   For:  5/26/23   ·   Accession #:  1558370-23-10719   ·   File #:  1-37581

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML      5K 
 2: EX-10.1     Material Contract                                   HTML    667K 
 6: R1          Document and Entity Information                     HTML     47K 
 9: XML         IDEA XML File -- Filing Summary                      XML     12K 
 7: XML         XBRL Instance -- acrs-20230526x8k_htm                XML     16K 
 8: EXCEL       IDEA Workbook of Financial Report Info              XLSX      8K 
 4: EX-101.LAB  XBRL Labels -- acrs-20230526_lab                     XML     46K 
 5: EX-101.PRE  XBRL Presentations -- acrs-20230526_pre              XML     31K 
 3: EX-101.SCH  XBRL Schema -- acrs-20230526                         XSD     13K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               11±    17K 
11: ZIP         XBRL Zipped Folder -- 0001558370-23-010719-xbrl      Zip    126K 

‘8-K’   —   Current Report

This is an HTML Document rendered as filed.  [ Alternative Formats ]

2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/27/24  Aclaris Therapeutics, Inc.        10-K       12/31/23   91:11M                                    Toppan Merrill Bridge/FA
 8/07/23  Aclaris Therapeutics, Inc.        10-Q        6/30/23   69:7.5M                                   Toppan Merrill Bridge/FA